Hematopoietic Stem Cell Transplantation Market to Reach $8.57B by 2030 at 11% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Hematopoietic Stem Cell Transplantation Market During 2026–2030?
The hematopoietic stem cell transplantation market size has experienced rapid expansion in recent years. It is forecast to grow from $5.1 billion in 2025 to $5.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.6%. This historical growth can be linked to factors like the increasing prevalence of hematologic disorders, the expansion of transplant centers, advancements in donor matching techniques, the rising adoption of autologous transplants, and improvements in supportive care protocols.
The hematopoietic stem cell transplantation market is projected to experience substantial expansion in the upcoming years. This market is forecast to reach $8.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.0%. This anticipated growth during the forecast timeframe is attributable to several factors, including the rising acceptance of gene-modified stem cell therapies, increased funding for transplant infrastructure, the broadening scope of allogeneic transplant procedures, a heightened emphasis on individualized transplant methods, and improved post-transplant survival outcomes. Key trends foreseen over this period encompass the growing prevalence of peripheral blood stem cell transplants, the escalating utilization of cord blood transplantation, the deeper integration of precision conditioning regimens, the enlargement of donor registry networks, and an intensified focus on follow-up monitoring after transplantation.
Access Your Free Sample Report For In-Depth Market Analysis:
What Primary Drivers Are Shaping The Hematopoietic Stem Cell Transplantation Market?
The increasing occurrence of blood cancer is expected to boost the growth of the hematopoietic stem cell transplantation market. Blood cancers are a group of malignancies that impact the development and operation of blood cells, with leukemia, lymphoma, and myeloma being the three main types. Hematopoietic stem cell transplantation is generally used to treat blood cancer by replacing stem cells and bone marrow cells killed by the malignancy. These new stem cells can then move to the bone marrow and start creating new blood cells. These factors therefore stimulate the hematopoietic stem cell transplantation market. For instance, in September 2025, according to Cancer Research UK, a UK-based charity, from 2024 to 2026, the incidence rate of leukemia in the UK is estimated at approximately 17.9 cases per 100,000 people per year, and it is projected to decrease by 3% to around 17.4 per 100,000 by 2038 to 2040. Hence, the heightened frequency of blood cancer drives the hematopoietic stem cell transplantation market.
What Are The Key Segment Divisions In The Hematopoietic Stem Cell Transplantation Market Segment Structure?
The hematopoietic stem cell transplantation market covered in this report is segmented –
1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Specialty Clinics
Subsegments:
1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation
2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation
What Trends Are Affecting The Growth Of The Hematopoietic Stem Cell Transplantation Market?
Leading companies engaged in hematopoietic stem cell transplantation are concentrating on developing innovations, such as digital tools, to streamline patient management, enhance donor matching protocols, and supply real-time data analytics for improved decision-making. Digital resources refer to various online instruments, platforms, or materials that provide information, services, or functionalities in an electronic format. For instance, in September 2024, BioLineRx Ltd., an Israel-based biopharmaceutical company, launched Mobilization Matters, a digital resource. Mobilization Matters is an interactive platform designed to inform healthcare professionals and patients about the mobilization of stem cells for transplantation. It offers comprehensive directives, best practices, and real-time monitoring tools to optimize the stem cell collection process, thereby enhancing patient outcomes and ensuring efficient resource utilization in transplantation procedures.
Which Organizations Are Engaged In The Hematopoietic Stem Cell Transplantation Market?
Major companies operating in the hematopoietic stem cell transplantation market are Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.
Get The Full Hematopoietic Stem Cell Transplantation Market Report:
Which Region Accounts For The Largest Portion Of The Hematopoietic Stem Cell Transplantation Market?
North America was the largest region in the hematopoietic stem cell transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Hematopoietic Stem Cell Transplantation Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Hematopoietic Stem Cell Transplantation Market 2026, By The Business Research Company
Human Embryonic Stem Cells Market Report 2026
https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report
Bone Marrow Transplantation Market Report 2026
https://www.thebusinessresearchcompany.com/report/bone-marrow-transplantation-global-market-report
Stem Cells Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
